• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myeloma.

作者信息

Boyd Kevin D, Walker Brian A, Wardell Christopher P, Ross Fiona M, Gregory Walter M, Davies Faith E, Morgan Gareth J

出版信息

Leuk Lymphoma. 2010 Nov;51(11):2126-9. doi: 10.3109/10428194.2010.509893. Epub 2010 Sep 21.

DOI:10.3109/10428194.2010.509893
PMID:20858096
Abstract
摘要

相似文献

1
High expression levels of the mammalian target of rapamycin inhibitor DEPTOR are predictive of response to thalidomide in myeloma.雷帕霉素抑制剂DEPTOR的哺乳动物靶点高表达水平可预测骨髓瘤患者对沙利度胺的反应。
Leuk Lymphoma. 2010 Nov;51(11):2126-9. doi: 10.3109/10428194.2010.509893. Epub 2010 Sep 21.
2
DEPTOR expression and response to thalidomide: toward a new therapeutic target in multiple myeloma?DEPTOR的表达与对沙利度胺的反应：多发性骨髓瘤的新治疗靶点？
Leuk Lymphoma. 2010 Nov;51(11):1960-1. doi: 10.3109/10428194.2010.527410.
3
Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3.硼替佐米测试剂量的药物基因组学鉴定出蛋白酶体基因的过度表达，尤其是 PSMD4，作为在接受 Total Therapy 3 治疗的骨髓瘤中的新型高危特征。
Blood. 2011 Sep 29;118(13):3512-24. doi: 10.1182/blood-2010-12-328252. Epub 2011 May 31.
4
Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.敲低DEPTOR可通过抑制PI3K/AKT活性来抑制人多发性骨髓瘤RPMI-8226细胞的增殖并增加对美法仑的化疗敏感性。
J Int Med Res. 2013 Jun;41(3):584-95. doi: 10.1177/0300060513480920. Epub 2013 Apr 15.
5
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents.血清游离轻链检测在接受新型药物一线治疗的多发性骨髓瘤患者早期复发检测及复发后预后预测中的作用
Haematologica. 2017 Mar;102(3):e104-e107. doi: 10.3324/haematol.2016.154070. Epub 2016 Dec 1.
6
Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide.Cereblon 表达是来那度胺和泊马度胺抗骨髓瘤活性所必需的。
Blood. 2011 Nov 3;118(18):4771-9. doi: 10.1182/blood-2011-05-356063. Epub 2011 Aug 22.
7
Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome.接受沙利度胺治疗的多发性骨髓瘤患者：评估临床参数、细胞因子、血管生成标志物、肥大细胞和骨髓CD57 + 细胞毒性T细胞作为预后预测指标。
Haematologica. 2007 Aug;92(8):1075-82. doi: 10.3324/haematol.11208. Epub 2007 Jul 20.
8
BAG3 regulates multiple myeloma cell proliferation through FOXM1/Rb/E2F axis.BAG3通过FOXM1/Rb/E2F轴调节多发性骨髓瘤细胞的增殖。
Cancer Gene Ther. 2020 Feb;27(1-2):108-111. doi: 10.1038/s41417-019-0154-2. Epub 2019 Dec 5.
9
Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells.一种DEPTOR-mTOR抑制剂在多发性骨髓瘤细胞中的细胞毒性特性
Cancer Res. 2016 Oct 1;76(19):5822-5831. doi: 10.1158/0008-5472.CAN-16-1019. Epub 2016 Aug 16.
10
DEPTOR expression negatively correlates with mTORC1 activity and tumor progression in colorectal cancer.DEPTOR表达与结直肠癌中mTORC1活性及肿瘤进展呈负相关。
Asian Pac J Cancer Prev. 2014;15(11):4589-94. doi: 10.7314/apjcp.2014.15.11.4589.

引用本文的文献

1
Regulatory role of DEPTOR‑mediated cellular autophagy and mitochondrial reactive oxygen species in angiogenesis in multiple myeloma.DEPTOR 介导的细胞自噬和线粒体活性氧在多发性骨髓瘤血管生成中的调控作用。
Int J Mol Med. 2021 Feb;47(2):643-658. doi: 10.3892/ijmm.2020.4831. Epub 2020 Dec 24.
2
Prognostic and clinicopathological significance of DEPTOR expression in cancer patients: a meta-analysis.DEPTOR表达在癌症患者中的预后及临床病理意义：一项荟萃分析
Onco Targets Ther. 2018 Aug 22;11:5083-5092. doi: 10.2147/OTT.S167355. eCollection 2018.
3
HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair.
HMGB1 敲低通过调节自噬和 DNA 损伤修复增加 MM 细胞的易损性。
J Exp Clin Cancer Res. 2018 Aug 29;37(1):205. doi: 10.1186/s13046-018-0883-3.
4
Intravesical Thalidomide boosts bacillus Calmette-Guérin (BCG) in non-muscle invasive bladder cancer treatment.经尿道沙利度胺增强卡介苗在非肌肉浸润性膀胱癌治疗中的作用。
Med Oncol. 2017 Dec 4;35(1):3. doi: 10.1007/s12032-017-1067-2.
5
DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma.DEPTOR维持浆细胞分化并对多发性骨髓瘤的预后产生有利影响。
J Hematol Oncol. 2017 Apr 18;10(1):92. doi: 10.1186/s13045-017-0461-8.
6
Deptor: not only a mTOR inhibitor.Deptor：不仅仅是一种mTOR抑制剂。
J Exp Clin Cancer Res. 2017 Jan 13;36(1):12. doi: 10.1186/s13046-016-0484-y.
7
Small molecule therapeutics targeting F-box proteins in cancer.针对癌症中F-box蛋白的小分子疗法。
Semin Cancer Biol. 2016 Feb;36:105-19. doi: 10.1016/j.semcancer.2015.09.014. Epub 2015 Sep 30.
8
DEPTOR is linked to a TORC1-p21 survival proliferation pathway in multiple myeloma cells.DEPTOR与多发性骨髓瘤细胞中的TORC1-p21生存增殖途径相关联。
Genes Cancer. 2014 Nov;5(11-12):407-19. doi: 10.18632/genesandcancer.44.
9
The genetic architecture of multiple myeloma.多发性骨髓瘤的遗传结构
Adv Hematol. 2014;2014:864058. doi: 10.1155/2014/864058. Epub 2014 Apr 3.
10
Understanding the multiple biological aspects leading to myeloma.了解导致骨髓瘤的多种生物学因素。
Haematologica. 2014 Apr;99(4):605-12. doi: 10.3324/haematol.2013.097907.